Genevieve Ubeaud-sequier

Genevieve Ubeaud-sequier


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2016 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
FNFlore Nardella
Flore Nardella
MBMorgane Beck
Morgane Beck
PCPierre Collart-Dutilleul
Pierre Collart-Dutilleul
GBGuillaume Becker
Guillaume Becker
CBCoralie Boulanger
Coralie Boulanger
GUGenevieve Ubeaud-sequier
Genevieve Ubeaud-sequier

11 February 2013 in Cytometry Part A
Verified
Journal Article
Open access
PDF file
LSLea Saab
Lea Saab
JPJean Peluso
Jean Peluso
CMChristian D. Muller
Christian D. Muller
GUGenevieve Ubeaud-sequier
Genevieve Ubeaud-sequier
Idiosyncratic drug-induced hepatotoxicity accounts for about 13% of all cases of acute liver failure, therefore cited as the most frequent reason for post-marketing drug withdrawal. Despite this, the underlying mechanisms remain poorly understood due to lack in adequate screening assays and predictive in vitro models. Hepatic transporters play a crucial role in the absorption, distribution, and elimination of both endogenous substrates and xenobiotics. Defects in transporter function can lead to altered drug disposition, including toxicity and loss of efficacy. Inflammation is one condition for demonstrated variable drug response, attributed in part, to changes in function of drug transporters. The present study investigates the implication of two important hepatic transporters (MDR1 and MRP2) in idiosyncratic drug-induced hepatotoxicity in the presence and absence of an inflammatory context. The synergistic effect of idiosyncratic drugs (Trovafloxacin, nimesulide, telithromycin, and nefazodone) and inflammatory stimuli (TNF-α + LPS) on the efflux activity of hepatic transporters was studied using microvolume cytometry. Our results demonstrated on the one hand that both MDR1 and MRP2 are variably implicated in idiosyncratic drug-induced liver injury and on the other hand that the occurrence of an inflammatory reaction during idiosyncratic drug therapy can noticeably modulate this implication. In the absence of an inflammatory stress, none of the four tested drugs modulated the efflux activity of MRP2; nevertheless telithromycin and nefazodone inhibited the efflux activity of MDR1. Upon occurrence of an inflammatory stress, the inhibitory potential of trovafloxacin, nimesulide, and nefazodone on the efflux activity of MRP2 was noticeably revealed, while the telithromycin and nefazodone-induced inhibition of MDR1 was clearly attenuated. Knowledge of underlying mechanisms may significantly contribute to elimination of potential hepatotoxic drugs long before marketing and to prevention of drug-induced hepatotoxicity. © 2013 International Society for Advancement of Cytometry

14 July 2012 in European Journal of Hospital Pharmacy
Verified
Journal Article
Closed access
PDF file
EPEmilie Petit-Jean
Emilie Petit-Jean
LPLaurent Perello
Laurent Perello
CHCéline Hernandez
Céline Hernandez
ADAnne-Cécile Gairard Dory
Anne-Cécile Gairard Dory
BGBénédicte Gourieux
Bénédicte Gourieux
GUGenevieve Ubeaud-sequier
Genevieve Ubeaud-sequier
Purpose The aim of this study was to evaluate the microbiological and physicochemical stability of 15 mg/ml ranitidine hydrochloride suspension. Methods 15 mg/ml ranitidine hydrochloride suspensions were prepared in commercial vehicle (ORA-BLEND). Suspensions were kept for 90 days at 4 °C and 25 °C. The microbiological stability was assessed by microbial enumeration tests and specific search for Escherichia coli The physical stability was assessed by colour change, pH and chromatogram peaks. Ranitidine was assayed using high-performance liquid chromatography. Each series of three batches at each storage condition was combined into one representative exponential curve for the evolution of degradation of ranitidine suspension. Stability was defined as a remaining concentration of at least 95 % of the initial concentration (ie, 5% degradation). Results Culture of the different suspension samples resulted in no bacterial or fungal growth. Specific search for E coli was negative. There was colour change for each batch. No change from the initial pH (4·2) occurred in samples stored at 4°C but, for samples stored at 25°C, the pH increased from 4·2 to 4·9. Unidentified peaks corresponding to degradation products appeared on the chromatogram at day 30 for suspensions stored at 25°C and at day 60 for suspensions stored at 4°C. Conclusions Ranitidine hydrochloride suspension in amber glass was stable for up to 27 days when stored at 4°C and up to 5 days at 25°C. It is recommended that nurses should allow ranitidine suspension to reach room temperature before use and administration to patients.